LENSAR (NASDAQ:LNSR) Stock Price Down 0.9%

Shares of the medical technology company fell slightly on Thursday.

Mar. 13, 2026 at 4:36am

Got story updates? Submit your updates here. ›

LENSAR, Inc. (NASDAQ:LNSR), a company that specializes in advanced laser systems for ophthalmic surgery, saw its stock price drop 0.9% during trading on Thursday. The stock traded as low as $11.58 and closed at $11.68, with approximately 57,433 shares traded, up 54% from the average daily volume.

Why it matters

LENSAR's stock performance is closely watched by investors and analysts as the company's flagship product, the LENSAR Laser System, is a key player in the cataract surgery market. The slight dip in stock price may be due to broader market conditions or investor sentiment, but it's important to monitor the company's financial health and competitive position in the industry.

The details

Several research analysts have commented on LENSAR's stock, with Wall Street Zen upgrading the shares to a "hold" rating and Weiss Ratings reissuing a "sell (d-)" rating. The company has a market cap of $139.46 million, a P/E ratio of -2.66, and a beta of 0.66. LENSAR's stock has a 50-day simple moving average of $12.01 and a 200-day simple moving average of $11.79.

  • LENSAR's stock price dropped 0.9% during trading on Thursday, March 13, 2026.

The players

LENSAR, Inc.

A medical technology company specializing in advanced laser systems for ophthalmic surgery, headquartered in Orlando, Florida.

Got photos? Submit your photos here. ›

The takeaway

The slight dip in LENSAR's stock price is worth monitoring, as the company's performance in the cataract surgery market is crucial to its long-term success. Investors and analysts will likely continue to closely follow the company's financial results and product developments in the coming quarters.